Dose Effect Evaluation and Therapeutic Window of the Neuro-EPO Nasal Application for the Treatment of the Focal Ischemia Model in the Mongolian Gerbil

Cerebrovascular disease is the third leading cause of death and the leading cause of disability in Cuba and in several developed countries. A possible neuroprotective agent is the rHu-EPO, whose effects have been demonstrated in models of brain ischemia. The Neuro-EPO is a derivative of the rHu-EPO...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Teste, Iliana Sosa, Tamos, Yuneidys Mengana, Cruz, Yamila Rodríguez, Cernada, Adriana Muñoz, Rodríguez, Janette Cruz, Martínez, Nelvis Subirós, Antich, Rosa Maria Coro, González-Quevedo, Alina, Rodríguez, Julio Cesar García
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: The Scientific World Journal 2012
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3366217/
https://ncbi.nlm.nih.gov/pubmed/22701364
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1100/2012/607498
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller